tion and with age in patients with catheterization. Conclusions: The 24-hour pad test immediately after catheter removal could indicate the need for early and active intervention to prevent continuous postoperative UI. Patients' symptoms and clinical items predictive of test positivity should be carefully assessed.
Background
The prevalence of benign prostatic hyperplasia (BPH) is high; in the United States, for example, approximately 4.5 million people received primary diagnoses at hospitals in 2000 [1] and in Japan, the number of patients with BPH reportedly increased from 135,000 in 1987 to 418,000 in 2011 [2] . Additionally, the percentage of Japanese men who will likely require treatment for BPH ranges from 2% at age 40-49 years to 12% at age 70-79 years, indicating an increasing trend with aging [3] [4] [5] .
Various therapies have been used to treat BPH. The use of surgical treatment is increasing, partly because the overall expenses associated with surgery are lower than those incurred with oral medications administered according to the Japanese Urological Association guidelines [3, 6] . Notably, holmium laser enucleation of the prostate
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However, urinary incontinence (UI) after HoLEP remains a serious problem for patients. Continued UI after prostate surgery has been reported to deteriorate a patient's health-related quality of life (QOL), as measured by instruments such as the EuroQOL-5 Dimension and Short Form 12-Item Survey [11] ; accordingly, UI after HoLEP is thought to similarly influence the health-related QOL. Some reports have described the preoperative prognosticators of post-HoLEP UI [12] [13] [14] and have devised procedures to prevent this complication [15] . However, it is challenging to address this issue because many patients are poorly compliant after surgery (i.e., do not regularly visit hospitals); additionally, no sufficient evaluation method has been established because of the lack of a clear and unified standard, in contrast to the post-surgical follow-up procedures for cases involving malignant diseases such as prostate cancer.
Hence, we considered the potential usefulness of an index that would allow simple evaluations to be conducted as early as possible postoperatively. Regarding radical prostatectomy for prostate cancer, which causes similar problems with postoperative continence, urine leakage is checked immediately after postoperative catheter removal using the pad test and has been reported as a prognosticator of recovery from incontinence [16] [17] [18] [19] ; in contrast, no such studies have been conducted among patients who have undergone HoLEP. In this study, we examined whether the amount of urine leakage on day 1 following catheter removal might also be a prognosticator of incontinence after HoLEP.
This study aimed to identify the following points. First, to address the practical measure of secondary postoperative continuous UI prevention, we examined the relationships of the pad test results immediately after HoLEP with continence acquisition soon (3 months) after surgery and with the timing of continence acquisition, while considering long-term postoperative aspects. Second, we studied the postoperative and perioperative factors related to pad test positivity immediately after surgery as a practical measure of primary prevention.
Methods

Subjects
Patients who underwent HoLEP at St. Luke's International Hospital, Tokyo, Japan from July 2008 to September 2014 and had undergone a 24-hour pad test immediately after postoperative catheter removal were retrospectively examined via chart review. Pelvic floor muscle training (PFMT) involved only instruction via a pamphlet given to patients with a high level of UI at the time of discharge and those with a long duration of UI in outpatient settings after HoLEP (without clear criteria and at the doctor's discretion). Patients included in this study did not receive direct PFMT from a physiotherapist. In addition, anticholinergic drugs, beta 3-adrenoceptor agonists, and/or clenbuterol were prescribed to postoperative outpatients at the physician's discretion.
Survey Method and Items
The following items were recorded from medical charts: age (years), body mass index (BMI; kg/m 2 ), preoperative prostate specific antigen (PSA; ng/ml), uroflowmetry, presence of catheterization or intermittent self-catheterization at the time of surgery, and duration of catheterization in catheterized patients. The subjective symptom evaluation incorporated results from the International Prostate Symptom Score (IPSS), IPSS-QOL [20, 21] , and Overactive Bladder Symptom Score (OABSS) questionnaires [22] . The IPSS comprises 7 questions related to voiding symptoms and filling symptoms, with possible total scores of 0-35 (asymptomatic to very symptomatic). The IPSS-QOL comprises a questionnaire that determines the patient's satisfaction with his/her current urination status, with possible scores of 0-6 (highly satisfied to very unsatisfied) [20, 21] . The OABSS, which is used to evaluate overactive bladder symptoms, comprises 4 questions regarding urgency, urinary frequency, and urgency incontinence, with possible total scores of 0-15 (mild to severe) [22] .
The evaluation of complications included the American Society of Anesthesiologists (ASA) classification of physical status (range 1-5, with low and high scores indicating healthy and serious patient statuses, respectively) [23] , diabetes mellitus (DM), smoking history, operation duration (min), combined operation status (including transurethral cystolithotripsy and transurethral resection of a bladder tumor (TURBT)), enucleation time (min), total energy (kJ), presence or absence of transurethral coagulation (TUC) due to the use of an electric knife for hemostasis, enucleated tissue weight (g), changes between the pre-and postoperative levels of hemoglobin (Hb; g/dl), pathological findings of malignancy, surgical complications, and the use or nonuse of preoperative oral medication for an overactive bladder. Patients who underwent TURBT combined with HoLEP were considered to have a bladder mucosal injury at the time of surgery.
Surgical Procedure
The surgical equipment used for these patients included a laser generator (VersaPulse 80/100W Holmium; Lumenis, Yokneam, Israel), 26-Fr continuous flow resectoscope (Karl Storz Endoskope, Tuttlingen, Germany) and nephroscope (Olympus Corporation, Tokyo, Japan), and morcellator (Lumenis). Surgeries were conducted via anteroposterior dissection [15] . In cases involving hemostatic difficulty, including surgeries conducted by 312 trainees or over a wide hemostatic area, TUC with an electric current was used for hemostasis. Morcellation was performed using the inverse technique [15, 24] . A total of 14 operators performed surgeries.
The 24-Hour Pad Test and Definition of UI in Outpatient Settings
Following surgery, the urethral catheter was removed on postoperative day 2 (88.6% of patients) or thereafter. The 24-hour pad test was conducted immediately after catheter removal. For this test, the patient wore 1 or more pieces of UI padding for 24 h after catheter removal to measure the leakage weight, calculated as the difference between the pad weights before and after use. The mode was 0 g, under which 56.8% of the analyzed subjects' results were placed. Accordingly, the subjects were divided into 2 groups: leakage weight = 0 g and leakage weight >0 g. Patient complaints of UI during postoperative outpatient interviews were considered clinically significant and defined as UI, whereas continence acquisition was defined as no reported leakage. All reported complaints of UI were recorded as such; no distinction was made between stress UI (SUI) and urgent UI (UUI) [11] .
Analytical Methods
Continuous variables were presented as medians, as most of the studied variables were not normally distributed. To examine the results of questionnaires regarding the preoperative urination condition, subjects were divided as those without catheterization who provided answers to a questionnaire about urination status, and those with catheterization at the time of surgery or self-catheterization before the examination. Only patients for whom the maximum urinary flow rate (Qmax) information from preoperative uroflowmetry were available at the time of surgery, who had completed the IPSS [20, 21] and OABSS [22] , and who had received the total laser energy dose were subject to evaluation. Fisher's exact test was used to compare the occurrence of complications between patients with and without catheterization at the time of surgery.
The chi-square test was used to examine the potential relationship between the UI status during a 24-hour pad test immediately after postoperative catheter removal and the UI status at 3 months postoperatively. In addition, the sensitivity and specificity of pad test-detected UI immediately after postoperative catheter removal were calculated with respect to the UI status at 3 months postoperatively. Regarding the long-term postoperative evaluation of continence, the log-rank test was performed to evaluate the possible relationship between the UI status according to a 24-hour pad test immediately after postoperative catheter removal and the timing of continence acquisition. A correlation analysis was conducted to investigate the potential relationship between the 24-hour pad test UI weight immediately after postoperative catheter removal and the timing of postoperative continence acquisition. Additional sub-analyses evaluated only patients with and without catheterization who underwent surgery conducted by an operator who had performed the highest number of surgeries, as well as the surgeries of patients without catheterization who reported no leakage on the preoperative OABSS questionnaire.
The Mann-Whitney U test, chi-square test, and Fisher's exact test were used to compare between subjects and non-subjects of the study and to conduct univariate analyses of factors related to the presence or absence of UI during the 24-hour pad test immediately after postoperative catheter removal. A multivariate logistic regression analysis was also performed. The evaluated items included age, BMI, preoperative and postoperative PSA, DM status, smoking history, ASA classification, total laser energy, enucleated tissue weight, use of TUC for hemostasis, combined operation status, changes between pre-and postoperative Hb levels, and pathological findings of malignancy. The IPSS/IPSS-QOL/OABSS symptom scores and Qmax in patients without catheterization at the time of surgery and the catheterization duration of patients with catheterization at the time of surgery were also examined. Regarding factors related to the presence or absence of UI in the 24-hour pad test immediately after postoperative catheter removal, the inputted factors were chosen based on examinations of internal correlations in which the correlation coefficient was checked using continuous variables. The coefficients between the morcellation duration and enucleated tissue weight, the total laser energy and enucleated tissue weight, and the operation duration/enucleation time and total energy were >0.7. Accordingly, the evaluation of UI-associated factors incorporated the enucleated tissue weight and total energy.
Differences were considered statistically significant at a p value <0.05. All statistical analyses were performed using IBM SPSS version 21 (SPSS Inc., Chicago, Ill., USA). This study was approved by the institutional review boards of Fukushima Medical University and St. Luke's International Hospital (Nos. 1543 and 14R-122, respectively), which waived the need for consent.
Results
Comparison between Subjects and Non-Subjects
A total of 687 patients underwent the 24-hour pad test immediately after catheter removal, including 532 patients without catheterization and 155 patients with catheterization at the time of surgery. According to information collected from medical charts, 341 patients without catheterization and 150 patients with catheterization at the time of surgery met the study criteria and were included in this study ( fig. 1 ) . No significant differences were detected with respect to age, BMI, ASA classification, PSA level, and enucleated tissue weight between the subjects and non-subjects from among both patients with and without catheterization at the time of surgery.
Comparison of Patients with and without Catheterization at the Time of Surgery
A comparison of the subjects with and without catheterization indicated that the latter group had a significantly higher age, PSA level, 6 out of 8 operation-related items, and leakage amount during the 24-hour pad test immediately after catheter removal (p < 0.05; without catheterization at the time of surgery: perioperative transfusion, 0 (0.0%) and 1 case (0.7%); hemostasis during re-surgery, 5 (1.5%) and 0 cases (0.0%); febrile urinary tract infection, 4 (1.2%) and 4 cases (2.7%); and postoperative urethral stricture, 20 (5.9%) and 5 cases (3.3%). None of these differences was significant. When patients who underwent TURBT as a combined operation were included, 2 patients (0.6%) without and 7 patients (4.7%) with catheterization at the time of surgery experienced bladder mucosal injury, indicating a significantly higher incidence among patients with urinary retention at the time of surgery (p < 0.01). Pathologically, malignancy was observed in the enucleation specimens of 26 patients (7.6%) without and 10 patients (6.7%) with urinary retention at the time of surgery; this difference was not significant (no table presented).
The Presence or Absence of UI during the 24-Hour Pad Test Immediately after Catheter Removal and at 3 Months Postoperatively
In patients without catheterization at the time of surgery, a significant relationship was observed between the UI status in the 24-hour pad test immediately after catheter removal and the UI status at 3 months postoperatively (p < 0.01). The sensitivity and specificity of the UI status during the 24-hour pad test immediately after catheter removal for predicting the UI status at 3 months postoperatively were 80.0 and 66.5%, respectively. Similarly, in patients with catheterization at the time of surgery, a significant relationship was observed between the UI status during the 24-hour pad test immediately after catheter removal and the UI status at 3 months postoperatively (p < 0.01). In that group, the sensitivity and the 314 specificity of the UI status during the 24-hour pad test immediately after catheter removal for predicting the UI status at 3 months postoperatively were 88.0 and 53.6%, respectively. Furthermore, in a receiver operating characteristic curve analysis of the relationship between continence acquisition at 3 months postoperatively and the 24-hour pad test immediately after surgery among all subjects (i.e., patients with and without catheterization before surgery were combined), the area under the curve was 0.778, indicating moderate accuracy, and the sensitivity and specificity at a cut-off value of 0 g were 78.6 and 60.4%, respectively.
The 24-Hour Pad Test Immediately after Catheter Removal and the Timing of Postoperative Continence Acquisition
Among patients without catheterization at the time of surgery, an examination of the UI status during the 24-hour pad test immediately after catheter removal and the timing of continence acquisition indicated a significant correlation ( fig. 2 ; p < 0.01). In addition, a significant correlation was detected between the 24-hour pad test UI amount immediately after catheter removal and the timing of continence acquisition (rs = 0.655, p < 0.01). A subanalysis of 189 subject patients without catheterization (55.4% of the patients without catheterization) who underwent surgery performed by an operator who had performed the highest number of surgeries revealed a significant relationship between the presence or absence of UI during the 24-hour pad test immediately after catheter removal and the timing of continence acquisition (p < 0.01), as well as a correlation between the 24-hour pad test UI amount immediately after catheter removal and the timing of continence acquisition (rs = 0.790, p < 0.01). Another sub-analysis included the 176 subject patients without catheterization at the time of surgery (51.6% of patients without catheterization) who had not complained of incontinence before surgery. Significant relationships were observed between the presence and absence of UI during the 24-hour pad test immediately after catheter removal and the timing of continence acquisition (p = 0.01), and between the 24-hour pad test UI amount immediately after catheter removal and the timing of continence acquisition (rs = 0.655, p < 0.01). Among patients with catheterization at the time of surgery, an examination of the presence or absence of UI during the 24-hour pad test immediately after catheter removal and the timing of continence acquisition revealed a significant correlation ( fig. 3 ; p < 0.01). In addition, a significant correlation was observed between the 24-hour pad test UI amount immediately after catheter removal and the timing of continence acquisition (rs = 0.735, p < 0.01). A sub-analysis of 64 subject patients with urinary retention (42.7% of the patients with catheterization) who underwent surgery performed by an operator who had performed the highest number of surgeries revealed a significant relationship between the presence and absence of UI during the 24-hour pad test immediately after catheter removal and the timing of continence acquisition (p < 0.01), as well as a correlation between the 24-hour pad test UI amount immediately after catheter removal and the timing of continence acquisition (rs = 0.803, p < 0.01).
Factors Related to the UI Status during the 24-Hour Pad Test Immediately after Catheter Removal
Among patients without catheterization at the time of surgery, the univariate analysis identified the enucleated tissue weight (p < 0.01) and total preoperative OABSS score (p = 0.02) as factors significantly related to the presence or absence of UI during the 24-hour pad test immediately after catheter removal. No significant associations with other items, including age and the presence or absence of DM, were detected ( table 2 ). The multivariate analysis also identified the total preoperative OABSS score (p = 0.04) and enucleated tissue weight (p < 0.01) as factors significantly related to the presence or absence of UI during the 24-hour pad test immediately after catheter removal ( table 3 ) . In contrast, among patients with catheterization at the time of surgery, the univariate analysis identified age (p = 0.04) as the only factor related to the presence or absence of UI during the 24-hour pad test immediately after catheter removal; no significant relationships were detected with other items ( table 4 ). 
Discussion
In agreement with previous studies conducted after radical prostatectomy for prostate cancer [16] [17] [18] [19] , our present study demonstrated that the results of a pad test conducted immediately after post-HoLEP catheter removal correlated with postoperative continence acquisition, regardless of the catheterization status at the time of surgery, and revealed that the pad test is a practical secondary prevention measure of PFMT. In our study, the UI amount measured during the immediately postoperative 24-hour pad test was examined using a cut-off value of 0 g, the most frequent value. Previous studies have used cut-off values of 50, 100, 200, and 500 g [16] , as well as 0 and 99 g [19] , and the application of the cut-off values of 50, 100, 200, and 500 g as references in our present study yielded (sensitivity, specificity) values of (0.686, 0.831), (0.557, 0.887), (0.429, 0.923), and (0.200, 0.954), respectively. Whether a UI amount of 0 or >0 g during the immediately postoperative pad test is more sensitive appears to be a simple practical measure of short-term postoperative continence acquisition, without a great loss of specificity.
In this study, an inpatient 24-hour pad test was conducted immediately after catheter removal. Notably, the length of hospital stay in each country is significantly influenced by the medical system. As the average length of hospital stay for acute phase treatment in Japan is lon- , the Japanese medical system can support hospital stays of 24 h after postoperative catheter removal. In many Japanese facilities, doctors observe patients' courses following catheter removal for a full day during hospitalization. However, because the 24-hour pad test can be performed at a patient's home, we consider it a highly pragmatic and practical measure of secondary prevention, even in settings other than 24-hour in-patient postoperative care. This method could also be widely utilized for evaluation of recently developed treatments in various clinical settings [26, 27] . Regarding practical measures for the primary prevention of continuous postoperative UI, the factors related to UI during a pad test conducted immediately after catheter removal were OABSS score and enucleated tissue weight in patients without catheterization at the time of surgery, and age in patients with catheterization. Notably, relationships were observed with subjective complaints (preoperative OAB symptoms) and a clinical measure (enucleated tissue weight) in patients without catheterization. SUI is a frequent topic of focus when considering postHoLEP UI. Indeed, a previous study defined the postoperative mixed UI and use of a pad as SUI [13] . However, another report described the development of not only de novo SUI, but also de novo UUI after HoLEP [14] . In this study, we defined postoperative UI as that reported by a patient, which included any UI such as SUI, UUI, and dribbling after urination. We speculated that of the postoperative UIs, UUI might be related to the preoperative OABSS score. It is therefore important to listen carefully to patients' complaints of UI before surgery.
In previous studies, the patient factors associated with post-HoLEP UI included the (predicted) enucleated tissue weight, DM, and a high PSA reduction rate [12] ; the medical factors included the operator's surgical proficiency level [13] and bladder mucosal injury [14] at the time of surgery. However, no consensus has been reached regarding these factors. In this study, the patient factors associated with UI did not include DM, likely because many of the patients had achieved good DM control; in particular, the median HbA1c level among the 70 patients (14.2%) with comorbid DM was 7.0%, and only 3 (4.3%) diabetic patients had an HbA1c level >8.4%, indicating poor control.
Similarly, regarding the medical factors, bladder mucosal injuries occurred in 6 subjects (1.2%) in this study, or 9 subjects (1.8%) after including those who underwent combined procedures involving TURBT, which can be considered equivalent to bladder mucosal injury; both of these rates were very low. For this reason, we could not detect a relationship between bladder mucosal injury and postoperative continence acquisition. This is likely due to the adoption of morcellator surgery via the inverse technique [24, 28, 29] , which is associated with fewer complications. Even after considering the operator influence in one of sub-analyses, the UI status immediately after surgery was shown to be a good predictor of postoperative continence acquisition.
The limitations of this study include its retrospective design and the lack of comprehensive distribution and collection of IPSS and OABSS questionnaires among non-subject patients in this study, which resulted in a large number of patients without available questionnaire results. This study demonstrated that in both the univariate and multivariate analyses, the total OABSS score was significantly related to the 24-hour pad test outcome immediately after postoperative catheter removal in patients without catheterization. Therefore, an understanding of a patient's preoperative urination status is important to the postoperative follow-up. Doctors-in-charge will need to be aware of OAB symptoms during preoperative medical examinations.
Conclusion
This study revealed that an evaluation of UI conducted using an immediately postoperative pad test could constitute an index to recommend early and active intervention via PFMT as a secondary method for preventing continuous postoperative UI. Additionally, this evaluation will likely help to preoperatively predict and communicate the outcomes of patients undergoing surgery, as it comprises a factor related to the primary prevention of continuous postoperative UI in patients without catheterization who are expected to have intense overactive bladder symptoms and/or high enucleated tissue weights, as well as older patients with catheterization.
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